Assessment of batch to batch variation in polyclonal antithymocyte globulin preparations

Transplantation

Volumn 93, Issue 1, 2012, Pages 32-40

  Popow, Irene ^a   Leitner, Judith ^a   Majdic, Otto ^a   J Kovarik, Johannes ^b   D Saemann, Marcus ^b   Zlabinger, Gerhard J ^a   Steinberger, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antithymocyte globulins; Batch variations; Binding interactions; Cytotoxicity

Indexed keywords

CD147 ANTIGEN; CD2 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD82 ANTIGEN; CD98 ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; ANTIGEN BINDING; ARTICLE; BINDING COMPETITION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DRUG MANUFACTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LEUKEMIA CELL LINE; LEUKOCYTE; LYMPHOCYTE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; ANTILYMPHOCYTE SERUM; CELL DEATH; CELL LINE; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; HUMANS; IMMUNOMODULATION; JURKAT CELLS; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MICE; MIDDLE AGED; MONOCYTES; RABBITS; THYMUS GLAND; TREATMENT OUTCOME;

EID: 84655161865     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31823bb664     Document Type: Article

References (24)

1. Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 2007; 21: 1387.
2. Bonnefoy-Berard N, Genestier L, Preville X, et al. TNF alpha and CD95-L contribute to apoptosis of activated lymphocytes triggered by ATGs. Transplant Proc 1999; 31: 775.
3. Bonnefoy-Berard N, Genestier L, Flacher M, et al. Apoptosis induced by polyclonal antilymphocyte globulins in human B-cell lines. Blood 1994; 83: 1051.
4. Michallet MC, Preville X, Flacher M, et al. Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 2003; 75: 657.
5. Leitner J, Grabmeier-Pfistershammer K, Majdic O, et al. Interaction of antithymocyte globulins with dendritic cell antigens. Am J Transplant 2011; 11: 138.
6. Bonnefoy-Berard N, Revillard JP. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant 1996; 15: 435.
7. Zand MS, Vo T, Pellegrin T, et al. Apoptosis and complementmediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. Blood 2006; 107: 2895.
8. Monti P, Allavena P, Di Carlo V, et al. Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol 2003; 3: 189.
9. Starzl TE, Marchioro TL, Porter KA, et al. The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet 1967; 124: 301.
10. Brennan DC, Daller JA, Lake KD, et al. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006; 355: 1967.
11. Gaber AO, First MR, Tesi RJ, et al. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation 1998; 66: 29.
12. Mariat C, Alamartine E, Diab N, et al. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients. Transpl Int 1998; 11: 231.
13. Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007; 297: 1568.
14. Zand MS. B-cell activity of polyclonal antithymocyte globulins. Transplantation 2006; 82: 1387.
15. Zand MS, Vo T, Huggins J, et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 2005; 79: 1507.
16. Wakabayashi H, Cook DJ, Posner M, et al. Batch-to-batch variations in rabbit antithymocyte globulin preparations. Transplant Proc 1991; 23(1 Pt 2): 1125.
17. Bourdage JS, Hamlin DM. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation 1995; 59: 1194.
18. Bonnefoy-Berard N, Vincent C, Revillard JP. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 1991; 51: 669.
19. Rebellato LM, Gross U, Verbanac KM, et al. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation 1994; 57: 685.
20. Broady R, Yu J, Levings MK. ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells. Blood 2009; 114: 5003.
21. Pfistershammer K, Lawitschka A, Klauser C, et al. Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients. Blood 2009; 114: 2323.
22. Leitner J, Klauser C, Pickl WF, et al. B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction. Eur J Immunol 2009; 39: 1754.
23. Leitner J, Kuschei W, Grabmeier-Pfistershammer K, et al. T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells. J Immunol Methods 2010; 362: 131.
24. Steinberger P, Majdic O, Derdak SV, et al. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol 2004; 172: 2352.